Market News & Analysis

Top Story

Gold: Clear Breakout Still Awaited

Spot gold saw swing trading in the last few sessions, amid conflicting news regarding a potential coronavirus vaccine development. On Monday, U.S. biotech firm Moderna announced positive results for a coronavirus vaccine trial. However a day later, health-oriented news agency STAT questioned the company's report, pointing out that it did not provide critical data and it would be impossible to draw a conclusion.

The precious metal briefly surpassed its high marked in April, though a follow-through is still yet to be seen. Yesterday, the latest Federal Reserve monetary meeting minutes reiterated the message that the Fed "was committed to using its full range of tools to support the U.S. economy". Meanwhile, Bloomberg data showed that total ETF holdings of gold rose for a 19th straight session on Wednesday, suggesting persistent investors' demand.


From a technical point of view, spot gold remains on the upside as shown on the 1-hour chart. Currently, it is trading within a bullish channel drawn from May 1, while staying above its previous trading range marked in the first half of this month. The level at $1,726 might be considered as the nearest support level, with prices likely to test the 1st and 2nd resistance at $1,765 and $1,776 respectively. Alternatively, a break below may signal a downturn and open a path to $1,711 and $1,691.

Source: TradingView, Gain Capital

Join our live webinars for the latest analysis and trading ideas. Register now

GAIN Capital UK Limited (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.